Remote temperature monitoring devices may enable early detection of febrile neutropenia in adults with acute myeloid leukemia (AML) who have undergone high-dose cytarabine consolidation chemotherapy before discharge from the hospital, a new study suggests.
Sometimes fever is the only initial symptom of febrile neutropenia, which can lead to acute renal, respiratory or heart failure, and has a roughly 11% mortality rate (J Oncol Pract 2018;14[4]:250-255), the study investigators noted during a